| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A rational relationship: Oncolytic virus vaccines as functional partners for adoptive T cell therapy
|
Burchett, Rebecca
|
|
|
56 |
C |
p. 149-159
|
artikel
|
| 2 |
Cytokines in oncolytic virotherapy
|
Pol, Jonathan G.
|
|
|
56 |
C |
p. 4-27
|
artikel
|
| 3 |
Determinants of the efficacy of viro-immunotherapy: A review
|
de Graaf, J.F.
|
|
|
56 |
C |
p. 124-132
|
artikel
|
| 4 |
Developing oncolytic viruses for clinical use: A consortium approach
|
Kemp, Vera
|
|
|
56 |
C |
p. 133-140
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
56 |
C |
p. ii
|
artikel
|
| 6 |
Engineering and combining oncolytic measles virus for cancer therapy
|
Leber, Mathias F.
|
|
|
56 |
C |
p. 39-48
|
artikel
|
| 7 |
Kinase inhibitors with viral oncolysis: Unmasking pharmacoviral approaches for cancer therapy
|
Gilchrist, Victoria Heather
|
|
|
56 |
C |
p. 83-93
|
artikel
|
| 8 |
Mechanisms of measles virus oncolytic immunotherapy
|
Pidelaserra-Martí, Gemma
|
|
|
56 |
C |
p. 28-38
|
artikel
|
| 9 |
Oncolytic Immunotherapy: Can’t Start a Fire Without a Spark
|
Muscolini, Michela
|
|
|
56 |
C |
p. 94-101
|
artikel
|
| 10 |
Oncolytic viral immunotherapy in the time of COVID-19
|
Olagnier, David
|
|
|
56 |
C |
p. 1-3
|
artikel
|
| 11 |
Oncolytic virotherapy for pancreatic ductal adenocarcinoma: A glimmer of hope after years of disappointment?
|
Tassone, Evelyne
|
|
|
56 |
C |
p. 141-148
|
artikel
|
| 12 |
Redirecting oncolytic viruses: Engineering opportunists to take control of the tumour microenvironment
|
Jamieson, Taylor R.
|
|
|
56 |
C |
p. 102-114
|
artikel
|
| 13 |
The pros and cons of interferons for oncolytic virotherapy
|
Geoffroy, Karen
|
|
|
56 |
C |
p. 49-58
|
artikel
|
| 14 |
The role of cancer metabolism in defining the success of oncolytic viro-immunotherapy
|
Dyer, Arthur
|
|
|
56 |
C |
p. 115-123
|
artikel
|
| 15 |
The two-faces of NK cells in oncolytic virotherapy
|
Marotel, M.
|
|
|
56 |
C |
p. 59-68
|
artikel
|
| 16 |
Tumour vasculature: Friend or foe of oncolytic viruses?
|
Santry, Lisa A.
|
|
|
56 |
C |
p. 69-82
|
artikel
|
Tijdschrift beschrijving